(Australia-NewsWire.Com, April 26, 2017 ) Middle-East and Africa attention deficit hyperactivity disorder (ADHD) therapeutics market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 9.31 % to reach USD 1.30 billion by 2021, from USD 0.83 billion in 2016.
Attention deficit hyperactivity disorder (ADHD), is one of most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children whose age is less than twelve years as compared to adolescents. ADHD Market is also described as the hyperkinetic disorder/ attention deficit disorder or neuropsychiatric disorder. The exact cause for ADHD is not clear but, expected to be resulted due to environmental influences and genetic factors. ADHD results in improper functioning of nervous system that led to hyperactivity/impulsiveness and attention deficit condition.
Key factors which affects and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report. Some of those factors are
Rising investments in research & development growing number of neurological patients increasing funds from public organizations towards better health rising awareness about attention deficit hyperactivity disorder improper healthcare infrastructure scarcity of trained healthcare professionals low success rates of ADHD therapeutics utilization
For granular level understanding the attention deficit hyperactivity disorder (ADHD) therapeutics market is segmented based on type and application, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Medication Stimulants-Amphetamines Non-Stimulants-Bupropion Based on Psychotherapy Behavior Therapy Cognitive Behavioral Therapy Based on Education or Training Parent Management Training Family Therapy
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, KSA, UAE, Nigeria and Algeria.
Some of the key players that operate in the Middle-East and Africa attention deficit hyperactivity disorder (ADHD) therapeutics market include Shire plc (Ireland), Eli Lilly and Company (U.S.), Neos Therapeutics, Inc. (U.S.), Pfizer Inc. (U.S.), Supernus Pharmaceuticals, Inc. (U.S.), Alcobra Ltd. (Israel), Noven Pharmaceuticals, Inc. (U.S.), Johnson & Johnson (U.S.), Novartis AG (Switzerland), and Curemark, LLC. (U.S.)
The Middle-East and Africa attention deficit hyperactivity disorder (ADHD) therapeutics market report offers wide-range of scope:
Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailed Segment-level analysis on basis of Medication, Psycotheraphy, Education or training along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the pharmaceuticals Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.